Navigation Links
Dasatinib, Nilotinib show strong early results as frontline therapy for chronic myelogenous leukemia
Date:12/9/2007

percent at three months, 54 percent at six months and 65 percent at a year. For high-dose imatinib the historical response rates were 62 percent, 82 percent and 86 percent.

As frontline treatment, imatinib has increased the 5-year survival rate for CML patients from 50 percent to 90 percent. Imatinib targets the aberrant Bcr-Abl protein, caused by a chromosomal abnormality called the Philadelphia Chromosome, which fuels an overabundance of white blood cells and immature stem cells called blasts that crowd out red blood cells and platelets.

Nilotinib and Dasatinib target a greater variety of genetic variations leading to CML than does imatinib.

Both clinical trials continue to enroll patients. Side effects are being closely monitored and some patients in each trial had their doses reduced or treatment temporarily interrupted to deal with toxicities. "We can't say at this moment that either drug has major problems with side effects," Cortes said.

The trials tap M. D. Anderson's longstanding expertise in all three drugs. M. D. Anderson was a leader in the registration clinical trial that led to approval of imatinib for CML.

"As some of our patients started to develop resistance to imatinib, we started searching for agents to bypass that resistance, working with the pharmaceutical companies to test new agents," says Hagop Kantarjian, M.D., chair of M. D. Anderson's Department of Leukemia.

Kantarjian developed, designed and conducted the clinical trials that led to approval of nilotinib by the FDA last month for patients who can no longer take imatinib.

Moshe Talpaz, M.D., developed, designed and conducted clinical trials that led to approval of dasatinib by the FDA in June 2007 for the same group of patients. Talpaz is now at the University of Michigan.

Cortes is leading research into a third drug, bosutinib, produced by Wyeth Pharmaceuticals, as a second-line therapy for CML. (Please see separate n
'/>"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-516-4855
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Smoking may strongly increase long-term risk of eye disease
2. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
3. Family History Has Strong Effect on Cardiac Risk
4. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
5. New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare
6. Dynatronics Announces Strong Fourth Quarter Profit
7. New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
8. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
9. Armstrong Kids Get in Step with Good Health
10. Chubby Checker Adds Twist to 10,000 Strong at Ninth Annual Walk to Cure Cancer for UMass Memorial Cancer Center at the UMass Medical School
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Parkulture is proud to announce that ... Jared “JJ” Woods, will be competing on NBC’s highest ... The show will premiere on local affiliates this coming ... the new Esquire Network on Tuesday, July 29th at ... balancing careers as a professional stuntman for film and ...
(Date:7/25/2014)... 25, 2014 Eye & Vision has ... their office location by expanding a new specialized ocular ... comprehensive visual electro-physiology clinic. , By acquiring specialized Visual ... experience in vision problems, patients with vision loss in ... advantage of the implementation of this specialized vision testing ...
(Date:7/25/2014)... 25, 2014 The report “Canada ... provides company shares and distribution shares data for ... profiles of the key market participants, pipeline products, ... market wherever available. , The data in the ... Rsearcher uses epidemiology and capital equipment-based models to ...
(Date:7/25/2014)... NH, 7/25/14) Researchers at Dartmouth-Hitchcock Norris Cotton Cancer ... system so it recognizes and attacks invading cancer cells. ... accepting everything as normal, even while cancer cells ... discussed in a review article published this week in ... jumpstart the body,s ability to fight tumors. Nanoparticles ...
(Date:7/25/2014)... 2014 The American Brain Tumor Association ... Development Trainer of Distinguished Events, and Corporate and Special ... Cancer Society, will be joining the ABTA in the ... will oversee the roll out of a nationwide brain ... The recently launched volunteer network will provide the Chicago-based ...
Breaking Medicine News(10 mins):Health News:Jared “JJ” Woods Prepares for American Ninja Warrior City Finals 2Health News:Jared “JJ” Woods Prepares for American Ninja Warrior City Finals 3Health News:Eye & Vision, a Leading Eye Doctor Group in Richardson, Celebrate Milestone and Expand Scope of Specialized Eye Care 2Health News:Eye & Vision, a Leading Eye Doctor Group in Richardson, Celebrate Milestone and Expand Scope of Specialized Eye Care 3Health News:Canada Cystoscopes, Laryngoscopes & Ureteroscopes Market Forecast to 2020 Reports Available at MarketOptimizer.org 2Health News:Canada Cystoscopes, Laryngoscopes & Ureteroscopes Market Forecast to 2020 Reports Available at MarketOptimizer.org 3Health News:Canada Cystoscopes, Laryngoscopes & Ureteroscopes Market Forecast to 2020 Reports Available at MarketOptimizer.org 4Health News:Canada Cystoscopes, Laryngoscopes & Ureteroscopes Market Forecast to 2020 Reports Available at MarketOptimizer.org 5Health News:Scientists test nanoparticle 'alarm clock' to awaken immune systems put to sleep by cancer 2Health News:American Brain Tumor Association Recruits Director to Lead New Volunteer Network 2
... ... most wanted gifts for UK mums this Mother,s Day , ... London, UK (PRWEB) March 4, 2010 -- Voucher codes website Savoo.co.uk ... Boots voucher codes travel and clothing are the top three most desired gifts by ...
... ... Kidney Diseases recommends capsaicin as an effective skin care regimen to help relieve itching associated ... be extremely hot. Now there,s a new skin spray made with the essence of hot ... ...
... ... Weight Loss program. With documented success in other parts of the country, doctors Dan Buchanan ... to Cincinnati. , ... (PRWEB) March 4, 2010 -- UniqueU Medical Weight Loss Program opened in Kenwood, a ...
... ASTHMA HAVE INCREASED HEALTH RISKS , Pregnant women with ... symptoms and fetal growth abnormalities. Researchers from the Medical ... asthma to determine the effect of active and passive ... the women, 418 (18 percent) reported active smoking; among ...
... say they "had sex," what transpired is anyone,s guess. A ... that no uniform consensus existed when a representative sample of ... them. Is oral sex considered sex? It wasn,t ... anal sex? For around 20 percent of the participants, no. ...
... ... ... ... ...
Cached Medicine News:Health News:Voucher Site Savoo.co.uk Reveals What Mum's Really Want This Mother's Day 2Health News:Hot Pepper Itch Remedy Targets Kidney Disease Patients Suffering From Chronic Pruritus 2Health News:UniqueU Medical Weight Loss Program Opens Cincinnati Location 2Health News:News briefs from the March issue of Chest 2Health News:IU study finds no consensus in definitions of 'had sex' 2Health News:IU study finds no consensus in definitions of 'had sex' 3Health News:UMDNJ Online Graduate Certificate in Aging Program Accepting Applications 2Health News:UMDNJ Online Graduate Certificate in Aging Program Accepting Applications 3Health News:UMDNJ Online Graduate Certificate in Aging Program Accepting Applications 4Health News:UMDNJ Online Graduate Certificate in Aging Program Accepting Applications 5Health News:UMDNJ Online Graduate Certificate in Aging Program Accepting Applications 6
(Date:7/25/2014)... July 25, 2014 NOT FOR RELEASE, ... INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO ... REGULATIONS OF SUCH JURISDICTION AbbVie (NYSE: ABBV ) ... 30, 2014. "This was another very strong ... share above our original guidance and announced plans to merge ...
(Date:7/24/2014)...   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... for Zalviso remains July 27, 2014.  The ... the Food and Drug Administration (FDA) had approved Zalviso.  ... notification to the company from the FDA regarding the ...
(Date:7/24/2014)... , July 24, 2014  Restore Health, ... and compounded pharmaceuticals, announced that it is now ... unique to each individual based upon their particular ... by understanding the interaction between a patient,s genetics ... "We,re very excited to provide this new service ...
Breaking Medicine Technology:AbbVie Reports Second-Quarter 2014 Financial Results 2AbbVie Reports Second-Quarter 2014 Financial Results 3AbbVie Reports Second-Quarter 2014 Financial Results 4AbbVie Reports Second-Quarter 2014 Financial Results 5AbbVie Reports Second-Quarter 2014 Financial Results 6AbbVie Reports Second-Quarter 2014 Financial Results 7AbbVie Reports Second-Quarter 2014 Financial Results 8AbbVie Reports Second-Quarter 2014 Financial Results 9AbbVie Reports Second-Quarter 2014 Financial Results 10AbbVie Reports Second-Quarter 2014 Financial Results 11AbbVie Reports Second-Quarter 2014 Financial Results 12AbbVie Reports Second-Quarter 2014 Financial Results 13AbbVie Reports Second-Quarter 2014 Financial Results 14AbbVie Reports Second-Quarter 2014 Financial Results 15AbbVie Reports Second-Quarter 2014 Financial Results 16AbbVie Reports Second-Quarter 2014 Financial Results 17AbbVie Reports Second-Quarter 2014 Financial Results 18AbbVie Reports Second-Quarter 2014 Financial Results 19AbbVie Reports Second-Quarter 2014 Financial Results 20AbbVie Reports Second-Quarter 2014 Financial Results 21AbbVie Reports Second-Quarter 2014 Financial Results 22AbbVie Reports Second-Quarter 2014 Financial Results 23AbbVie Reports Second-Quarter 2014 Financial Results 24AbbVie Reports Second-Quarter 2014 Financial Results 25AbbVie Reports Second-Quarter 2014 Financial Results 26AbbVie Reports Second-Quarter 2014 Financial Results 27AbbVie Reports Second-Quarter 2014 Financial Results 28AbbVie Reports Second-Quarter 2014 Financial Results 29AbbVie Reports Second-Quarter 2014 Financial Results 30AbbVie Reports Second-Quarter 2014 Financial Results 31AbbVie Reports Second-Quarter 2014 Financial Results 32AbbVie Reports Second-Quarter 2014 Financial Results 33AbbVie Reports Second-Quarter 2014 Financial Results 34AbbVie Reports Second-Quarter 2014 Financial Results 35AbbVie Reports Second-Quarter 2014 Financial Results 36
... YORK, Sept. 8 ACCESS PHARMACEUTICALS, INC. (OTC ... in products for cancer, supportive care, today announced that the ... Conference in New York City on Tuesday, September 14th at ... floor of the New York Palace Hotel.   ...
... GE Healthcare announced today that results from its ... the September issue of Annals of Neurology . ... agent being developed by GE Healthcare, in the field ... the phase 2 study was to investigate the efficacy ...
Cached Medicine Technology:Access Pharmaceuticals to Present At Rodman & Renshaw Annual Global Investment Conference in New York City 2Access Pharmaceuticals to Present At Rodman & Renshaw Annual Global Investment Conference in New York City 3Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology 2Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: